Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%

Business by 2FIRSTS.ai
Jul.22.2024
Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%
Smoore International (06969.HK) announces approval for seven e-cigarette products by RJ Reynolds Vapor Company through PMTA pathway.

On July 21, the Hong Kong-listed company Smoore International (06969.HK) announced that its customer, R.J. Reynolds Vapor Company, has been authorized through the Pre-Market Tobacco Product Application (PMTA) pathway to sell seven e-cigarette products in the United States starting July 18, 2024. The products include the Vuse Alto Power Unit and six closed, pre-filled, non-refillable Vuse Alto tobacco flavored pods: Vuse Alto Pod Golden Tobacco 5%, Vuse Alto Pod Rich Tobacco 5%, Vuse Alto Pod Golden Tobacco 2.4%, Vuse Alto Pod Rich Tobacco 2.4%, Vuse Alto Pod Golden Tobacco 1.8%, and Vuse Alto Pod Rich Tobacco 1.8%. According to Smoore International's sales records from the beginning of this year until the date of the announcement, the group has supplied these seven products to the RJR Group.

Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%


Smoore International expressed that they are greatly encouraged by their client R.J. Reynolds Vapor Company's successful premarket tobacco product application approval, believing that this will provide clearer guidance for the group to better deploy resources in the U.S. market.

Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%
Smoore International Announcement | Image source: Smoore International


As of the time of writing, Smoore International (06969) surged over 10% in early trading, reaching 9.5 Hong Kong dollars with a trading volume of 1.237 billion Hong Kong dollars.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.